Drug Shortage Report for SANDOZ PREGABALIN
Report ID | 29132 |
Drug Identification Number | 02390833 |
Brand name | SANDOZ PREGABALIN |
Common or Proper name | PREGABALIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 75MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100'S |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2017-10-30 |
Estimated end date | 2018-02-05 |
Actual end date | 2018-02-05 |
Shortage status | Resolved |
Updated date | 2018-02-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-11-13 | English | Compare |
v2 | 2017-11-13 | French | Compare |
v3 | 2018-01-08 | English | Compare |
v4 | 2018-01-08 | French | Compare |
v5 | 2018-02-06 | English | Compare |
Showing 1 to 5 of 5